BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2724295)

  • 1. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol).
    Rogers GA; Parsons SM; Anderson DC; Nilsson LM; Bahr BA; Kornreich WD; Kaufman R; Jacobs RS; Kirtman B
    J Med Chem; 1989 Jun; 32(6):1217-30. PubMed ID: 2724295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional vesamicol receptor occupancy and acetylcholine active transport inhibition in synaptic vesicles.
    Kaufman R; Rogers GA; Fehlmann C; Parsons SM
    Mol Pharmacol; 1989 Sep; 36(3):452-8. PubMed ID: 2550778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the vesamicol receptor in cholinergic synaptic vesicles by acetylcholine and an endogenous factor.
    Noremberg K; Parsons SM
    J Neurochem; 1989 Mar; 52(3):913-20. PubMed ID: 2537382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sidedness and chemical and kinetic properties of the vesamicol receptor of cholinergic synaptic vesicles.
    Kornreich WD; Parsons SM
    Biochemistry; 1988 Jul; 27(14):5262-7. PubMed ID: 2844255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic synaptic vesicle heterogeneity: evidence for regulation of acetylcholine transport.
    Gracz LM; Wang WC; Parsons SM
    Biochemistry; 1988 Jul; 27(14):5268-74. PubMed ID: 3167045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles.
    Bahr BA; Clarkson ED; Rogers GA; Noremberg K; Parsons SM
    Biochemistry; 1992 Jun; 31(25):5752-62. PubMed ID: 1319200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles.
    Anderson DC; King SC; Parsons SM
    Mol Pharmacol; 1983 Jul; 24(1):48-54. PubMed ID: 6865925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a receptor in Torpedo synaptic vesicles for the acetylcholine storage blocker L-trans-2-(4-phenyl[3,4-3H]-piperidino) cyclohexanol.
    Bahr BA; Parsons SM
    Proc Natl Acad Sci U S A; 1986 Apr; 83(7):2267-70. PubMed ID: 3457385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine transport and drug inhibition kinetics in Torpedo synaptic vesicles.
    Bahr BA; Parsons SM
    J Neurochem; 1986 Apr; 46(4):1214-8. PubMed ID: 3950625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsymmetrical bipiperidyls as inhibitors of vesicular acetylcholine storage.
    Efange SM; Khare A; Parsons SM; Bau R; Metzenthin T
    J Med Chem; 1993 Apr; 36(8):985-9. PubMed ID: 8478910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of quantal size by vesamicol (AH5183), an inhibitor of vesicular acetylcholine storage.
    Whitton PS; Marshall IG; Parsons SM
    Brain Res; 1986 Oct; 385(1):189-92. PubMed ID: 3768717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stoichiometries of acetylcholine uptake, release, and drug inhibition in Torpedo synaptic vesicles: heterogeneity in acetylcholine transport and storage.
    Anderson DC; Bahr BA; Parsons SM
    J Neurochem; 1986 Apr; 46(4):1207-13. PubMed ID: 3950624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spirovesamicols: conformationally restricted analogs of 2-(4-phenylpiperidino)cyclohexanol (vesamicol, AH5183) as potential modulators of presynaptic cholinergic function.
    Efange SM; Khare AB; Foulon C; Akella SK; Parsons SM
    J Med Chem; 1994 Aug; 37(16):2574-82. PubMed ID: 8057300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the acetylcholine transport blocker 2-(4-phenylpiperidino) cyclohexanol (AH5183) on the subcellular storage and release of acetylcholine in mouse brain.
    Carroll PT
    Brain Res; 1985 Dec; 358(1-2):200-9. PubMed ID: 4075114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of N,N'-dicyclohexylcarbodiimide on the binding of vesamicol, an inhibitor of acetylcholine transport into synaptic vesicles.
    Diebler MF
    Neurochem Int; 1992 Jul; 21(1):83-90. PubMed ID: 1303145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine transport: fundamental properties and effects of pharmacologic agents.
    Parsons SM; Bahr BA; Gracz LM; Kaufman R; Kornreich WD; Nilsson L; Rogers GA
    Ann N Y Acad Sci; 1987; 493():220-33. PubMed ID: 3035983
    [No Abstract]   [Full Text] [Related]  

  • 17. Acyclic analogues of 2-(4-phenylpiperidino)cyclohexanol (vesamicol): conformationally mobile inhibitors of vesicular acetylcholine transport.
    Efange SM; Michelson RH; Dutta AK; Parsons SM
    J Med Chem; 1991 Aug; 34(8):2638-43. PubMed ID: 1875353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation of cytosolic acetylcholine into synaptic vesicles and demonstration of vesicular release.
    Michaelson DM; Burstein M; Licht R
    J Biol Chem; 1986 May; 261(15):6831-5. PubMed ID: 3700417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: synthesis and biological evaluation.
    Efange SM; Khare AB; Mach RH; Parsons SM
    J Med Chem; 1999 Jul; 42(15):2862-9. PubMed ID: 10425095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In favour of the vesicular hypothesis: neurochemical evidence that vesamicol (AH5183) inhibits stimulation-evoked release of acetylcholine from neuromuscular junction.
    Vizi ES
    Br J Pharmacol; 1989 Nov; 98(3):898-902. PubMed ID: 2590773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.